cerrar
Tagged with access,

Laboratorios Duncan – Miriam Martinez, CEO –…
 Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded…

Boston Consulting Group Malaysia – Zarif Munir, Partner…
The managing director of Boston Consulting Group Malaysia discusses the gap between public and private healthcare in the country, and what can be done…

Interview: Wojciech Jezewski, Country Director, Medtronic Poland
Medtronic’s country director brings some interesting perspectives on the differences between the pharma and medical device regulations in Poland by…

Interview: Rui Ferreira Santos, Country Manager, Almirall…
Almirall Portugal stopped all commercial activity in 2011 to focus only on the market access of new, innovative products being introduced through the…

Interview: José Aranda da Silva, General Manager, Formifarma,…
José Aranda da Silva, General Manager of Formifarma Portugal, stresses the importance of market access, demonstrating added value for companies…

Interview: Christian L Macher, General Manager, AstraZeneca…
My advice for this market is to launch and see. The only way you can survive in here is if you have a lot of innovations, because then you don’t…

Interview: Ed Dybka, General Manager, Almirall Canada
Having only arrived on the market last year, the GM of Almirall in Canada explains the company's regulatory struggles, the utilization of Almirall’s…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here